Envestnet Asset Management Inc. Sells 3,906 Shares of Integer Holdings Corporation (NYSE:ITGR)

Envestnet Asset Management Inc. lowered its stake in Integer Holdings Corporation (NYSE:ITGR - Free Report) by 1.6% in the 1st quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 238,710 shares of the medical equipment provider's stock after selling 3,906 shares during the quarter. Envestnet Asset Management Inc. owned about 0.68% of Integer worth $28,170,000 at the end of the most recent quarter.

Several other institutional investors have also bought and sold shares of the stock. OneDigital Investment Advisors LLC raised its position in Integer by 14.1% in the first quarter. OneDigital Investment Advisors LLC now owns 1,969 shares of the medical equipment provider's stock worth $232,000 after acquiring an additional 243 shares in the last quarter. Principal Financial Group Inc. raised its position in Integer by 2.8% in the first quarter. Principal Financial Group Inc. now owns 187,290 shares of the medical equipment provider's stock worth $22,102,000 after acquiring an additional 5,023 shares in the last quarter. Teacher Retirement System of Texas bought a new stake in Integer in the first quarter worth about $579,000. Bessemer Group Inc. raised its holdings in Integer by 73.1% during the 1st quarter. Bessemer Group Inc. now owns 296 shares of the medical equipment provider's stock worth $35,000 after buying an additional 125 shares during the period. Finally, Yorktown Management & Research Co Inc acquired a new stake in Integer during the 1st quarter worth about $277,000. Institutional investors and hedge funds own 99.29% of the company's stock.

Analyst Ratings Changes

Several analysts have issued reports on the company. Truist Financial set a $150.00 price objective on Integer and gave the stock a "buy" rating in a report on Friday, April 25th. KeyCorp cut their price objective on Integer from $154.00 to $145.00 and set an "overweight" rating on the stock in a report on Monday, April 21st. Citigroup upgraded Integer from a "hold" rating to a "strong-buy" rating and boosted their price objective for the stock from $133.00 to $140.00 in a report on Thursday, May 22nd. Benchmark cut their price objective on Integer from $150.00 to $140.00 and set a "buy" rating on the stock in a report on Friday, April 25th. Finally, Raymond James Financial boosted their price objective on Integer from $145.00 to $150.00 and gave the stock an "outperform" rating in a report on Friday, April 25th. Two equities research analysts have rated the stock with a hold rating, seven have given a buy rating and one has issued a strong buy rating to the stock. According to data from MarketBeat.com, the company has a consensus rating of "Moderate Buy" and an average target price of $146.25.

Integer Stock Down 3.0%

Shares of NYSE ITGR traded down $3.50 during trading hours on Friday, hitting $111.15. The stock had a trading volume of 179,605 shares, compared to its average volume of 389,030. The company has a market capitalization of $3.88 billion, a P/E ratio of 52.67, a P/E/G ratio of 1.01 and a beta of 0.98. The firm's 50-day moving average price is $119.76 and its two-hundred day moving average price is $124.59. Integer Holdings Corporation has a 52 week low of $104.93 and a 52 week high of $146.36. The company has a debt-to-equity ratio of 0.78, a quick ratio of 2.14 and a current ratio of 3.40.

Integer (NYSE:ITGR - Get Free Report) last announced its quarterly earnings results on Thursday, April 24th. The medical equipment provider reported $1.31 EPS for the quarter, beating the consensus estimate of $1.27 by $0.04. The business had revenue of $437.39 million during the quarter, compared to analysts' expectations of $428.51 million. Integer had a return on equity of 11.95% and a net margin of 4.38%. The firm's quarterly revenue was up 7.3% compared to the same quarter last year. During the same quarter in the previous year, the business posted $1.14 EPS. Analysts anticipate that Integer Holdings Corporation will post 6.01 EPS for the current fiscal year.

Insider Activity at Integer

In other Integer news, Director Martin C. Maxwell sold 8,720 shares of the company's stock in a transaction that occurred on Thursday, June 5th. The stock was sold at an average price of $120.56, for a total transaction of $1,051,283.20. Following the completion of the sale, the director owned 22,170 shares of the company's stock, valued at $2,672,815.20. This represents a 28.23% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. Also, CEO Joseph W. Dziedzic sold 338,975 shares of the company's stock in a transaction that occurred on Thursday, May 1st. The stock was sold at an average price of $123.17, for a total value of $41,751,550.75. Following the sale, the chief executive officer directly owned 47,000 shares of the company's stock, valued at $5,788,990. The trade was a 87.82% decrease in their position. The disclosure for this sale can be found here. In the last quarter, insiders sold 362,434 shares of company stock valued at $44,577,115. 2.16% of the stock is owned by corporate insiders.

Integer Profile

Integer Holdings Corporation operates as a medical device outsource manufacturer in the United States, Puerto Rico, Costa Rica, and internationally. It operates through two segments, Medical and Non-Medical. The company offers products for interventional cardiology, structural heart, heart failure, peripheral vascular, neurovascular, interventional oncology, electrophysiology, vascular access, infusion therapy, hemodialysis, non-vascular, urology, and gastroenterology procedures.